Edward L. Murrelle

Biography

 Lenn Murrelle is co-founder, President and CEO of Venebio Group, LLC and of its subsidiary companies, Venebio Intellectual Property Development, LLC, and algorithmRx, LLC. Lenn has nearly 30 years of global experience developing, leading and contributing to large-scale research on disease understanding and prevention, pharmacoepidemiology, pharmacoeconomics, drug safety, treatment evaluation, bioinformatics, and biomarker discovery. Previously, Lenn was a director in Worldwide Epidemiology at GlaxoSmithKline Pharmaceuticals, where he led genetic and molecular epidemiology research for target identification and progression, new indications, and safety pharmacogenomics. Following GSK, he led genomic and post-genomic biomarker discovery studies through industry-academic-biotechnology collaborations focused on tobacco harm reduction and intellectual property prosecution development.

Research Interest

 pharmacoepidemiology, pharmacoeconomics, drug safety, treatment evaluation, bioinformatics, and biomarker discovery, Epidemiology , Pharmaceuticals, genetic and molecular epidemiology research